Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?
Ren Fail
; 43(1): 1311-1321, 2021 Dec.
Article
em En
| MEDLINE
| ID: mdl-34547972
ABSTRACT
Intravenous contrast media (CM) is often used in clinical practice to enhance CT scan imaging. For many years, contrast-induced nephropathy (CIN) was thought to be a common occurrence and to result in dire consequences. When treating patients with abnormal renal function, it is not unusual that clinicians postpone, cancel, or replace contrast-enhanced imaging with other, perhaps less informative tests. New studies however have challenged this paradigm and the true risk attributable to intravenous CM for the occurrence of CIN has become debatable. In this article, we review the latest relevant medical literature and aim to provide an evidence-based answer to questions surrounding the risk, outcomes, and potential mitigation strategies of CIN after intravenous CM administration.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Meios de Contraste
/
Injúria Renal Aguda
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article